Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Unither Pharmaceuticals
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Segment Specific Market Share === Unither Pharmaceuticals, a French company, specializes in crafting single-dose BFS units for the pharmaceutical market. This entity provides diverse packaging solutions encompassing ampoules, vials, and bottles. With a footprint spanning Europe, Asia, and North America, Unither reaps an annual revenue of roughly $175 million, commanding a market share of approximately 18%. Anticipatedly, the Blow Fill Seal (BFS) market is poised to ascend from $312.5 million in 2020 to $386.0 million by 2025, translating to a CAGR of 4.3% throughout the forecast period. The surge in demand for aseptic packaging, coupled with escalating generic drug requisites and pharmaceutical industry expansion, propels the BFS market's trajectory. In the Pharmaceutical Suppositories Global Market Report 2023, projections highlight the dynamic trajectory of the global pharmaceutical suppositories market. Forecasts indicate an ascent from $1.5 billion in 2022 to $1.59 billion in 2023, driven by a robust Compound Annual Growth Rate (CAGR) exceeding 5%. Subsequently, the pharmaceutical suppositories market is envisaged to expand further, reaching $1.9 billion by 2027, again demonstrating a CAGR exceeding 5%. This progression finds impetus in factors such as the aging demographic, heightened prevalence of kidney impairment or failure, and an increased occurrence of hemorrhoids. These dynamics collectively underpin the forthcoming growth of the pharmaceutical suppositories market. Although Unither doesn't lead the way in terms of market share it has a significant stake given its size. The global pharmaceutical suppositories market is concentrated, with a small number of large players in the market. Bayer AG was the largest competitor with a 23.2% share of the market, followed by Pfizer Inc., Novartis International Ag, Sanofi S.A., Intas Pharmaceuticals Ltd., '''Unither Pharmaceuticals,''' Cosette Pharmaceuticals Inc., Aenova Holding GmbH, Delpharm and Bliss GVS Pharma Ltd.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)